Cigna Corp. (CI) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY26 EPS Guidance
Tweet
Share
E-mail
Get Alerts CI Hot Sheet
Price: $275.83 -1.83%
Revenue Growth %: +4.2%
Financial Fact:
Mail order pharmacy revenues: 762M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +4.2%
Financial Fact:
Mail order pharmacy revenues: 762M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cigna Corp. (NYSE: CI) reported Q2 EPS of $7.78, $0.19 better than the analyst estimate of $7.59. Revenue for the quarter came in at $71.7 billion versus the consensus estimate of $70.18 billion.
GUIDANCE:
Cigna Corp. sees FY2026 EPS of $30.45, versus the consensus of $30.41.
For earnings history and earnings-related data on Cigna Corp. (CI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- BMO Capital Starts American Eagle Outfitters (AEO) at Market Perform
- Google and Blackstone data-center venture hits delays at key sites - Bloomberg
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
